Dear Esteemed Editorial Board Members and Colleagues,

We are happy to announce that in the newly released 2025 JCR, the Journal Impact Factor (JIF) for Hepatology International has surged from 6.1 to 7.8.

This leap of +1.7 is particularly remarkable against current macro-market trends:

As the post-pandemic citation boom cools, many dominant journals have plateaued or declined.

This is a direct result of your unwavering commitment and exceptional peer reviews.

Let us leverage this momentum to further solidify our position as a leading global tier-1 journal.

Thank you once again for your incredible dedication.

Warmest regards,

Omata M, Sarin S

Editor-in-Chiefs, Hepatology International

Asian Pacific Association for the Study of the Liver (APASL)